CDSCO warns of hacking risk in Medtronic insulin pumpsSeptember 6, 2019
India’s drug regulator has flagged an alert about Medtronic’s insulin pumps.
The Central Drugs Standard Control Organization (CDSCO) alert states that the company’s MiniMed 508 Insulin Pump and MiniMed Paradigm Series Insulin Pumps have cybersecurity risks wherein someone other than the patient can wirelessly connect to them, change its settings and control the delivery.
The alert came a week after the US health regulator issued a warning to patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks.
The US health regulator warned patients and health care providers that certain Medtronic MiniMed insulin pumps being recalled due to potential cybersecurity risks and recommends that patients using these models switch their insulin pump to models that are better equipped to protect against these potential risks.
The CDSCO has advised healthcare professionals, distributors and users and staff involved in the management of patients to check and see if the model and the software version of their insulin pump is affected. It has advised them to monitor blood glucose levels closely and immediately cancel any unintended boluses.
It also advised not to share the pump serial number, be attentive to pump notifications, alarms and alerts and connecting the Medtronic insulin pump in use to other Medtronic devices and software only.
The CDSCO stated that it has not received any complaints from the market on the issue nor is it aware of any confirmed reports of patient harm related to these potential cybersecurity risks.